💯🧬 Jake 🧬💯 retweeted
Part 2
What actually happens when you stop GLP-1 medications? And can tapering, exercise, or preserving muscle change the outcome?
The research is more nuanced than simply telling everyone they’ll need these medications forever.
Tapering vs. stopping abruptly
We still lack randomized trials directly comparing gradual tapering to zero against abrupt discontinuation.
SURMOUNT-MAINTAIN (Lancet, 2026) offers some insight. After 112 weeks, participants maintained weight reductions of:
• 21.9% with continued treatment
• 16.6% with reduced-dose treatment
• 9.9% after switching to placebo
Lower doses preserved substantially more weight loss than discontinuation, although approximately 25% of the reduced-dose group required rescue treatment.
Does exercise prevent regain?
One of the more interesting findings comes from research involving liraglutide.
Lundgren et al. (NEJM, 2021) investigated exercise, liraglutide, and their combination.
At the one-year post-treatment follow-up, participants originally assigned to exercise maintained weight loss considerably better than those receiving medication alone.
The medication-only group regained approximately 6 kg more.
Important limitation: Only 109 participants completed that follow-up, and we don’t yet have equivalent long-term evidence for tirzepatide.
What about muscle loss?
SURMOUNT-1 body-composition data suggest approximately 75% of weight lost on tirzepatide was fat mass, while 25% was lean mass.
But losing weight and regaining it aren’t necessarily symmetrical processes.
Research in postmenopausal women suggests lean mass lost during weight reduction may not return proportionally when fat is regained.
That’s one reason resistance training and adequate protein intake deserve more attention throughout treatment.
Can GLP-1s permanently reset your weight set point?
We don’t have convincing evidence of that.
In the STEP 1 extension, participants regained approximately two-thirds of their semaglutide-associated weight loss within a year of discontinuation.
A 2026 BMJ meta-analysis projected substantial weight regain following withdrawal, with newer GLP-1 therapies showing particularly rapid rebound.
These findings challenge the idea that temporary appetite suppression necessarily produces permanent biological changes.
My takeaway:
GLP-1 medications are extremely effective tools for weight reduction, but weight loss and long-term weight maintenance are two different challenges.
The evidence supports continued treatment for many patients. Reduced maintenance doses may offer another approach, and structured exercise appears promising.
What remains unproven is whether gradually tapering completely off newer GLP-1 medications can meaningfully prevent rebound.
Rather than arguing that everyone must stay on medication forever or that everyone should eventually discontinue, we need better research into individualized maintenance strategies.
That’s where the next generation of obesity research should focus.
Not medical advice.
#GLP1 #Tirzepatide #Semaglutide #MetabolicHealth #ObesityResearch #WeightLoss #ExerciseScience
Stopping tirzepatide is the part of the GLP-1 story that doesn’t fit into a before-and-after photo.
The clearest evidence comes from SURMOUNT-4 (Aronne et al., JAMA, 2024), a randomized withdrawal trial funded by Eli Lilly.
Stage one:
783 adults with obesity or overweight, without diabetes, received tirzepatide for 36 weeks.
The 670 participants who reached randomization had lost an average of 20.9% of their starting body weight.
Stage two:
Participants were randomized to continue tirzepatide or switch to placebo for another 52 weeks.
The results:
Continued tirzepatide: another 5.5% weight reduction.
Switched to placebo: 14% weight regain.
89.5% of participants continuing treatment maintained at least 80% of their initial weight loss.
Only 16.6% of the placebo group maintained that same threshold.
Here’s what people overlook.
At week 88, the placebo group was still approximately 9.9% below its original weight.
So no, everyone didn’t simply regain everything. But substantial weight regain was common.
What the trial didn’t establish:
Whether gradual tapering reduces rebound weight gain.
How resistance training and dietary interventions might influence weight maintenance.
How much of the regained weight consisted of fat versus lean tissue.
The takeaway?
Tirzepatide isn’t failing when weight returns after discontinuation.
Obesity is a chronic condition, and the biological mechanisms driving appetite and weight regulation don’t necessarily disappear because someone lost weight.
These medications may be better understood as long-term metabolic therapies rather than temporary weight-loss interventions.
That’s an important distinction when discussing expectations, treatment duration, and long-term outcomes.
#Tirzepatide #GLP1 #MetabolicHealth #WeightLoss #ObesityResearch #Biohacking #ClinicalResearch
For further context, I’m not flat out saying you can’t morning dose, but as I commented once below, it appears a lot of GHRH logic bled into HGH logic on YouTube, Reddit, X, etc when it’s completely different and timing is WAY less important for the food intake, as long as your not eating awhile after (strictly for the small edge of lipolysis HGH offers) alongside its plethora of other benefits.
Again, a small fake edge is the pointed out argument here, not an overall you can’t do this*
HGH belongs at night
This is supposed to be controversial. It’s supposed to draw attention. But it’s true if we’re talking about what’s more optimal, and what makes the most sense, for someone who wants to run it long-term.
I didn’t say convenient.
Someone taking it in the morning because they can’t sleep on it is choosing convenience with a side of “this works for me.” That can still be the right call for them. It just isn’t the most optimal use of the compound.
Your biggest natural GH pulse happens at night, tied to the first deep slow-wave sleep. In men, a large portion of daily output (often the majority) occurs early in sleep. That’s why protocols for GHRH analogs like CJC are commonly started at night when possible. The short pulse is less “punishing” long-term than exogenous GH, but the night preference is still there because it lines up with how the body is already set up, and because dosing some of them in the morning can mess with energy in ways people notice.
With actual HGH you’re replacing. You’re completing the picture if you’re already on the other hormones. You’re not just poking a secretagogue and hoping for a pulse; you’re putting the hormone in yourself. Nighttime keeps that closer to how the body is wired to use it.
A lot of videos and write-ups push morning dosing as “better for fat loss.” It has zero real advantage over nighttime for that. Literally zero beyond convenience if you can’t tolerate it at night. There is no magic extra fat burn from pinning when you wake up.
GH doesn’t go to work the second the needle comes out. After a subcutaneous shot, levels typically peak in the 3-6 hour range (often around 4-5 hours depending on site and individual). That’s when lipolysis is ramping hard, free fatty acids rise after the first couple of hours and stay elevated for a good window after. So even if you ate something reasonably close to a nighttime dose, by the time the peak and the strong lipolytic window hit, your insulin is usually in a much better place. You’re fasted for hours while the strongest effect is playing out. You wake up with fatty acids already mobilized.
Morning dosing flips that. People say “you’re already fasted when you wake up, so just pin and wait an hour.” But the peak and the strongest lipolysis aren’t happening in that first hour. They’re happening later, right as most people are eating breakfast and lunch. GH raises insulin resistance to a degree; it is counter-regulatory. Do you want that resistance peaking and playing out across your daytime meals, or largely while you’re sleeping and fasted? Just because you’re fasted at injection time doesn’t mean the work is done immediately. You’re more likely to be dealing with the insulin-resistance side of GH through the part of the day when you’re actually eating.
It’s not the end of the world, you still get GH in you, but it is not superior for fat loss, and over time it is the less clean setup unless you stay strictly fasted for 5-8 hours after the morning shot. Most people are not doing that.
Data on this lines up with the physiology. Evening dosing has been shown to produce higher peak GH levels, hold IGF-1 more steadily, and avoid the higher daytime insulin seen with morning dosing. Morning dosing has also been linked to higher markers of protein breakdown overnight. Total daily dose still matters more than the clock for body composition, but the single night dose is the cleaner physiological choice for most people.
For the “set it and forget it/I want to run this forever and monitor it” approach, nighttime is the move. It matches the natural rhythm, manages the insulin side better for daily life, and keeps the lipolytic window in the long overnight fast.
Different use cases exist, with higher performance doses where people split to avoid dumping too much at once (above roughly 5-6 IU for some), or pure IGF-1 chasing when stacked with TRT/AAS. Those are different goals.
For longevity-range or steady use, night is the straightforward answer.
If sleep is an issue, try to power through it for a stretch and let your body adjust if you can. It’s still the optimal window. Convenience is fine when you need it. Optimal is night.
HGH belongs at night
This is supposed to be controversial. It’s supposed to draw attention. But it’s true if we’re talking about what’s more optimal, and what makes the most sense, for someone who wants to run it long-term.
I didn’t say convenient.
Someone taking it in the morning because they can’t sleep on it is choosing convenience with a side of “this works for me.” That can still be the right call for them. It just isn’t the most optimal use of the compound.
Your biggest natural GH pulse happens at night, tied to the first deep slow-wave sleep. In men, a large portion of daily output (often the majority) occurs early in sleep. That’s why protocols for GHRH analogs like CJC are commonly started at night when possible. The short pulse is less “punishing” long-term than exogenous GH, but the night preference is still there because it lines up with how the body is already set up, and because dosing some of them in the morning can mess with energy in ways people notice.
With actual HGH you’re replacing. You’re completing the picture if you’re already on the other hormones. You’re not just poking a secretagogue and hoping for a pulse; you’re putting the hormone in yourself. Nighttime keeps that closer to how the body is wired to use it.
A lot of videos and write-ups push morning dosing as “better for fat loss.” It has zero real advantage over nighttime for that. Literally zero beyond convenience if you can’t tolerate it at night. There is no magic extra fat burn from pinning when you wake up.
GH doesn’t go to work the second the needle comes out. After a subcutaneous shot, levels typically peak in the 3-6 hour range (often around 4-5 hours depending on site and individual). That’s when lipolysis is ramping hard, free fatty acids rise after the first couple of hours and stay elevated for a good window after. So even if you ate something reasonably close to a nighttime dose, by the time the peak and the strong lipolytic window hit, your insulin is usually in a much better place. You’re fasted for hours while the strongest effect is playing out. You wake up with fatty acids already mobilized.
Morning dosing flips that. People say “you’re already fasted when you wake up, so just pin and wait an hour.” But the peak and the strongest lipolysis aren’t happening in that first hour. They’re happening later, right as most people are eating breakfast and lunch. GH raises insulin resistance to a degree; it is counter-regulatory. Do you want that resistance peaking and playing out across your daytime meals, or largely while you’re sleeping and fasted? Just because you’re fasted at injection time doesn’t mean the work is done immediately. You’re more likely to be dealing with the insulin-resistance side of GH through the part of the day when you’re actually eating.
It’s not the end of the world, you still get GH in you, but it is not superior for fat loss, and over time it is the less clean setup unless you stay strictly fasted for 5-8 hours after the morning shot. Most people are not doing that.
Data on this lines up with the physiology. Evening dosing has been shown to produce higher peak GH levels, hold IGF-1 more steadily, and avoid the higher daytime insulin seen with morning dosing. Morning dosing has also been linked to higher markers of protein breakdown overnight. Total daily dose still matters more than the clock for body composition, but the single night dose is the cleaner physiological choice for most people.
For the “set it and forget it/I want to run this forever and monitor it” approach, nighttime is the move. It matches the natural rhythm, manages the insulin side better for daily life, and keeps the lipolytic window in the long overnight fast.
Different use cases exist, with higher performance doses where people split to avoid dumping too much at once (above roughly 5-6 IU for some), or pure IGF-1 chasing when stacked with TRT/AAS. Those are different goals.
For longevity-range or steady use, night is the straightforward answer.
If sleep is an issue, try to power through it for a stretch and let your body adjust if you can. It’s still the optimal window. Convenience is fine when you need it. Optimal is night.
We are live!
peptideplugs.com/?ref=OPTIMI…
Research and informational purposes only!
🤝 Paid partnership
💯🧬 Jake 🧬💯 retweeted
New: four peptide sprays. Semax, Selank, Semax + Selank, and Oxytocin.
They’re big bottles. 15 mL each, with up to 76mg of peptide in a bottle, so the price per mg beats even our own vials. Semax works out to $1.64/mg, against $4 in the vial.
Every lot tested by Freedom Diagnostics in mg/mL, three samples each. Certificates on the product pages.
peptideplugs.com/product-cat…
Now live at Elite Research, capsules to follow soon after!
eliteresearchusa.com/?code=O…
For informational and research use only.
🤝 Paid partnership
“bUt jUsT MuTE thEM”
The reason not to is because then when someone wants to share a post to stir the pot, they have to manually screenshot.
It’s the little things..
Chefs kiss to X experience.
Another fucking reason for them to delay GTA 6.
Not falling for it.
BREAKING: Pentagon prepares every major US military base to operate for at least 90 days without outside electricity, fuel, water or supplies, anticipating a major war that could cripple power grids, break global supply chains and threaten critical infrastructure on US soil, per Fox News.
The plans include portable nuclear reactors, large-scale battery storage and microgrids able to disconnect installations from the civilian electrical grid entirely.
FLGR-242 has likely been the most controversial compound introduced into the grey market, at least in the time I’ve been on X.
For better or worse, it has drawn massive attention, interest, and quite literally an army of people hoping it fails, mostly for four main reasons:
-Disdain for Jay Campbell.
-How it was promoted on social media by BLL affiliates or general fans of the brand.
-The belief that if there had been any real progress on myostatin inhibition, every pro bodybuilder would already be using it-or Big Pharma would have moved on it.
-The price. It’s subjective based on individual needs, and with sales plus the ability to split vials (also with the former Slim-Assist product), most people spent far less than the advertised figures.
On the first point, Jay and his team behind the scenes have been nothing but helpful and mentoring to me. Honestly, every vendor I represent-from Elite to Plugs to BLL-has had the man at the top help me in my journey more than I can describe.
Everyone should be rooting for effective myostatin inhibition to become a reality, while also understanding the legitimate concerns that come with it, just like with most other compounds used in this space.
If this approach is ever refined, the core idea remains: when used carefully and monitored, it could be paired with other enhancements (AAS, HGH, testosterone) so you could potentially run lower doses of the AAS side and still achieve results that previously required higher amounts. That matters for reduced side effects overall while still supporting more anabolism. The logic is that easing the myostatin “brake” makes the job of AAS or other anabolic compounds a bit easier.
Most people can agree the concept is sound.
The lack of independent data on FLGR-242 itself is a completely legitimate concern-and one I understand. At the same time, it seems unlikely the team would push this far with patents and related development if they didn’t have some degree of confidence in the approach. Continuing to apply the same albumin-binding concept across additional products also suggests they see real value in the underlying technology rather than treating this as a one-off gamble.
It is genuinely one of the more exciting compounds to emerge in our space. Unfortunately, it took heavy criticism on X partly because some promoters claimed it would replace steroids. I’ve never said that, never thought that, and that kind of messaging sets marketing back significantly. I’ve consistently encouraged anyone considering the cost to make sure their foundation is solid first-ideally with a testosterone base and, in my view, HGH as a strong synergistic addition to the stack.
What FLGR-242 actually is, and how it fits the idea above
FLGR-242 is a research-chemical product marketed as an engineered follistatin analog. BLL describe it as a fragmented/modified version of follistatin-344 (based on an activin-sparing FS I-I-type isoform) fused to an albumin-binding construct. The claimed goals are selective myostatin (GDF-8) neutralization with reduced activin binding, plus a much longer circulating half-life (advertised around 19 days) via albumin hitchhiking so that dosing can be less frequent than with unmodified follistatin.
The underlying biology is real and well-established.
Myostatin is a key natural brake on muscle growth; neutralizing it (or follistatin’s ability to trap it) increases muscle mass and strength in animal models and in limited primate/gene-therapy human work with related follistatin approaches. Activin-sparing designs have been studied precisely to try to retain the muscle effect while dialing down broader TGF family interference. Albumin-binding tails are a proven half-life extension strategy used in approved drugs.
That said, FLGR-242 itself has no published sequence, no independent analytical characterization in the literature, and no registered human clinical trials. All performance and safety claims currently come from the sellers, affiliated anecdotes, and user reports rather than peer-reviewed data on this specific molecule. It is sold for research use only.
My core framing still holds: if a selective, longer-acting myostatin brake-easer works as intended and is used alongside a solid testosterone base (and ideally HGH), it could theoretically amplify the return on other anabolic tools and let people run them more conservatively. That synergy idea is exactly why the concept is interesting to people who already optimize hormones and training. It is not a steroid replacement-nor does it need to be for it to have value. It is another potential lever on the muscle-growth pathway that, if the engineering holds up, pairs with rather than substitutes for the compounds most users already rely on.
As with anything in this space, the lack of controlled human data on this exact construct means individual results, safety, and long-term effects remain uncertain. People who choose to explore it generally do so with the understanding that they are operating ahead of published evidence, with source quality, bloodwork, and fundamentals (training, nutrition, and hormonal base) mattering more than the compound itself. For those already dialed in and willing to accept the grey-market trade-offs, it remains one of the more conceptually promising new tools that has appeared in recent years.
I am still a supporter, a big fan, and not only with FLGR-242, I wish success to Mid-35, and many others in the space to create new avenues that people have the option to test out.
My personal experience with FLGR has been nothing short of great, and I believe is one of the closest things we the public can try out in the myostatin niche, that can give us lab rats some fun and unique progress in our journey.
💯🧬 Jake 🧬💯 retweeted
Bi-weekly reminder 👽: Comment under this post or DM me if you want in on the private Telegram. Still active and slowly rebuilding after the mass exodus weeks back!
Looking for people who will be active preferably in the mosh pit (general chat LOL) while I rebuild this new X account like a COD Prestige 😀🤘💪.
HGH is expensive. Don’t neuter it with crushed E2
This is actually going to a be funny point considering we all unanimously make fun of the testosterone ranges on lab work, and other markers like being concerned with creatine based EGFR, despite having a avalanche of reasons thats next to useless for 99% of lifters to even look at.
But when it comes to estrogen, despite men having zero symptoms of it being a issue (for the most part), they have this mystery ceiling in their head for it on lab work, and do fuck all they can do lower it lol.
A lot of people still treat E2 like the enemy that needs to be driven as low as possible, especially once they’re enhanced. The problem is that in men, estrogen actually supports the GH/IGF-1 system instead of working against it.
Estradiol (the main estrogen made from testosterone) helps drive GH signaling. Research has shown for years that the ability of testosterone to raise GH and IGF-1 largely depends on it aromatizing. Block that conversion or use something that doesn’t aromatize, and the response drops. Even when you’re injecting HGH, the surrounding hormonal environment still matters for how well that HGH turns into IGF-1 and how effectively your body uses it. Guys should see their IGF-1 on a fixed HGH dose move with their E2, higher E2 (within reason) tends to support better conversion until you hit the point where sides start.
Beyond the numbers, crashed estrogen just makes the whole environment worse. One of the biggest practical benefits of HGH is recovery and joint health. Tanked E2 is notorious for drying out your joints and making them ache. So while the HGH is trying to help you recover and stay durable, low estrogen is actively fighting that. You train through more pain, your volume or intensity drops, and the recovery advantage gets voided out pretty much.
It also affects the broader picture. Mood, sleep quality, drive, and that overall “full” anabolic feeling. HGH works better when the rest of your hormones aren’t in a depleted state. Running high test with basically no estrogen, or stacking a bunch of low-aromatizing compounds plus aggressive AI use, is a pretty reliable way to cap what the HGH can actually do for you.
None of this means you should let E2 run wild. The goal is still balance, enough to support IGF-1 conversion, joint comfort, and recovery without the high-E2 sides most guys want to avoid. But deliberately crushing it just because you’re on cycle or HGH is usually counterproductive. If your IGF-1 looks underwhelming relative to the dose you’re running, or recovery still feels off, check your E2 before you just add more HGH. A lot of the time the limiter isn’t the growth hormone, it’s the estrogen you suppressed to feel “dry” or “manly”, lol.
I will say IGF-1 in itself is pretty finicky, so once a established GH dose has been running awhile, I would likely want a average of IGF-1s rather than a one-and-done result.
I have been talking about HGH alot, but mainly because it’s the most interesting compound, the most complex, and has so many different ways people use it, that I'm always learning something new. It provides good engagement on X, while also drawing up new conversations, because even with this many months in I still don't think I have cracked the code on it lol.
💯🧬 Jake 🧬💯 retweeted
Devonta Smith - Out
Dontayvion Wicks - Out
Nolan Smith - Out
Jonathan Greenard - Out
Michael Carter II - Out
Live look at Saquon Barkley coming back for week 7



























